Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. Press Releases
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ASTELLAS PHARMA INC.
06/17ASTELLAS PHARMA  : Notice Regarding Impairment Loss Following the Termination of..
PU
06/16ASTELLAS PHARMA  : Transfers Five Legacy Products in Europe, Russia, CIS and Asi..
PU
06/09ASTELLAS PHARMA  : New Research Reflects Astellas' Commitment to Acute Myeloid L..
AQ
06/02ASTELLAS PHARMA  : Reviewing capabilities for sustainable growth - Astellas Will..
PU
05/20ASTELLAS PHARMA  : and Seagen Announce Updated Results from Two Trials of PADCEV..
AQ
05/19ASTELLAS PHARMA  : Seagen and Astellas Announce Updated Results from Two Trials ..
BU
05/18Astellas to Present Data from Expanding Oncology Portfolio During the 2021 AS..
AQ
05/12ASTELLAS PHARMA  : Notice Regarding Continuation of the Performance-linked Stock..
PU
05/06ASTELLAS PHARMA  : ' XTANDI (enzalutamide) Approved by European Commission for M..
PU
05/05ASTELLAS PHARMA  : ' XTANDI (enzalutamide) Approved by European Commission for M..
AQ
04/28ASTELLAS PHARMA INC.  : - Notice Regarding Impairment Loss for Investigational G..
AQ
04/28ASTELLAS PHARMA INC.  : - Change of Directors
AQ
04/27ASTELLAS PHARMA  : Change of Directors
PU
04/26ASTELLAS PHARMA  : Notice Regarding Impairment Loss for Investigational Gene The..
PU
04/20ASTELLAS PHARMA  : and Seagen Announce U.S. FDA Acceptance of Two Supplemental B..
AQ
04/20ASTELLAS PHARMA  : and Seagen Announce FDA Acceptance of Two Supplemental Biolog..
PU
04/13ASTELLAS PHARMA  : Updates 'Contact for Potential Acquisition of ' R&D Programs'..
AQ
04/04ASTELLAS PHARMA  : and TOA EIYO Announce Termination of Distribution Agreement
PU
04/01ASTELLAS PHARMA  : Establishes ' Gene Therapies' as its Global Gene Therapy Cent..
AQ
04/01ASTELLAS PHARMA  : and TB Alliance Enter into a New Collaborative Research Agree..
AQ
04/01ASTELLAS PHARMA  : Announces Termination of Co-promotion with Viatris for Lipito..
PU
03/29ASTELLAS PHARMA  : ' XOSPATA Meets Overall Survival Endpoint in COMMODORE Trial
PU
03/29ASTELLAS PHARMA INC.  : - European Medicines Agency Accepts Marketing Authorizat..
AQ
03/29ASTELLAS PHARMA  : Garners New Indication and New Product Formulation Approvals ..
AQ
03/29ASTELLAS PHARMA  : Receives Positive CHMP Opinion for XTANDI for Patients with M..
AQ
03/29ASTELLAS PHARMA  : Receives Positive CHMP Opinion for XTANDITM for Patients with..
AQ
03/26ASTELLAS PHARMA INC.  : - Doshisha University, Wakayama Medical University and A..
AQ
03/26ASTELLAS PHARMA  : Garners New Indication & New Product Formulation Approvals Fr..
PU
03/25ASTELLAS PHARMA  : Oncology Announces Grand Prize Winner of Fifth Annual C-3 Pri..
AQ
03/24ASTELLAS PHARMA  : Presentation Material for Astellas Rx+ Day(Media Seminar)
PU
03/19ASTELLAS PHARMA  : Efforts against the Spread of the Coronavirus Disease
AQ
03/11ASTELLAS PHARMA  : Submits New Drug Application for Enfortumab Vedotin in Japan
PU
03/01ASTELLAS PHARMA  : Notice Regarding Continuation of the Performance-linked Stock..
AQ
02/26ASTELLAS PHARMA  : Notice Regarding Continuation of the Performance-linked Stock..
PU
02/22ASTELLAS PHARMA  : Announces Positive Topline Results from Two Phase 3 Pivotal G..
AQ
02/19ASTELLAS PHARMA  : and Seagen Announce Submission of Two Supplemental Biologics ..
AQ
02/15SEAGEN  : and Astellas Announce Phase 3 Trial Results Demonstrating Survival Adv..
AQ
02/15ASTELLAS PHARMA  : and Seagen Announce Presentation of Results from PADCEV Pivot..
AQ
02/04ASTELLAS PHARMA  : XOSPATA Receives Conditional Approval by China's National Med..
AQ
02/04ASTELLAS PHARMA  : Announces Management Structure
AQ
02/01ASTELLAS PHARMA  : Returns Rights to EligardTM in Europe, Middle East, CIS, and ..
AQ
01/28ASTELLAS PHARMA INC.  : - Result of Open Innovation Challenge 'Astellas Rx+ Heal..
AQ
01/25ASTELLAS PHARMA INC.  : - Establishing New Manufacturing Lines for Aseptic Drug ..
AQ
01/14ACTINIUM PHARMACEUTICALS  : and Astellas Announce Research Collaboration Focused..
AQ
01/06ASTELLAS PHARMA INC.  : - FDA Accepts for Priority Review the New Drug Applicati..
AQ
2020ASTELLAS PHARMA  : Reports XOSPATA in Combination with Azacitidine Did Not Meet ..
AQ
2020ASTELLAS PHARMA  : Supports Recommendations of Task Force on Climate-related Fin..
AQ
2020ASTELLAS PHARMA INC.  : - Expansion of the Domestic Logistics Platform for Pharm..
AQ
2020VIATRIS  : Astellas and Viatris Announce Termination of Co-promotion, Succession..
AQ
2020Astellas Receives Approval of EVRENZO in Japan for the Treatment of Anemia of..
AQ
2020ASTELLAS PHARMA  : Launches a 'Contact for Potential Acquisition of ' R&D Progra..
AQ
2020ASTELLAS PHARMA  : to Present New Data on Gilteritinib in FLT3 Mutation-Positive..
AQ
2020ASTELLAS PHARMA INC.  : - XTANDI Approved by China NMPA for the Treatment of Non..
AQ
2020ASTELLAS PHARMA  : Completes Acquisition of iota Biosciences
AQ
2020ASTELLAS PHARMA  : Receives U.S. FDA Fast Track Designation for ASP5354, an Inve..
AQ
2020ASTELLAS PHARMA  : ITI Announces Promotion of Dr. Tim Coleman to SVP, Operations..
AQ
2020ASTELLAS PHARMA INC.  : - U.S. FDA Grants Fast Track Designation for ASP0367/MA-..
AQ
2020ASTELLAS PHARMA INC.  : - New Roxadustat Data in Anemia of Chronic Kidney Diseas..
AQ
2020ASTELLAS PHARMA  : China Update – Drug Patents
AQ
2020ASTELLAS PHARMA  : to acquire iota Biosciences
AQ
2020ASTELLAS PHARMA  : FibroGen to Present New Efficacy and Safety Analyses from Rox..
AQ
2020ASTELLAS PHARMA  : to Acquire iota Biosciences
BU
2020ASTELLAS PHARMA  : and Seagen Announce Positive Topline Results from Second Coho..
AQ
2020ASTELLAS PHARMA  : and LabCentral Announce Golden Ticket Winners, Helping Emergi..
AQ
2020ASTELLAS PHARMA  : Celebrates First-Ever Virtual Day of Service to Help Non-Prof..
AQ
2020ASTELLAS PHARMA  : and MBC BioLabs Announce Golden Ticket Competition to Help Bi..
AQ
2020ASTELLAS PHARMA  : Real-World Evidence Studies Provide Further Insight into Nega..
AQ
2020ASTELLAS PHARMA  : and University of Pittsburgh Announce Research Collaboration ..
AQ
2020ASTELLAS PHARMA INC.  : - Astellas Efforts against the Spread of the Coronavirus..
AQ
2020ASTELLAS PHARMA  : Collaborates with Two Research Centers at the University of T..
AQ
2020ASTELLAS PHARMA  : and Seattle Genetics Announce PADCEV Significantly Improved O..
AQ
2020ASTELLAS PHARMA  : and Seattle Genetics Announce PADCEV Significantly Improved O..
PU
2020ASTELLAS PHARMA INC.  : - Science-Based Fitness Service, Fit-eNce
AQ
2020ASTELLAS PHARMA  : Open Innovation Challenge Astellas Rx+ Healthcare Innovation ..
AQ
2020ASTELLAS PHARMA  : is Awarded Grant from the U.S. National Institutes of Health ..
AQ
1  2  3  4  5  6  7  8Next
Upcoming event on ASTELLAS PHARMA INC.